Table 1_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.docx by Qianyi Zhou (6196383)

“…</p>Results<p>Of these, 17 patients received tocilizumab, resulting in a significant reduction in the duration of grade 3 CRS compared to those who did not receive the drug. …”

Image 2_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff by Qianyi Zhou (6196383)

“…</p>Results<p>Of these, 17 patients received tocilizumab, resulting in a significant reduction in the duration of grade 3 CRS compared to those who did not receive the drug. …”

Table 2_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.doc by Qianyi Zhou (6196383)

“…</p>Results<p>Of these, 17 patients received tocilizumab, resulting in a significant reduction in the duration of grade 3 CRS compared to those who did not receive the drug. …”

Image 1_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff by Qianyi Zhou (6196383)

“…</p>Results<p>Of these, 17 patients received tocilizumab, resulting in a significant reduction in the duration of grade 3 CRS compared to those who did not receive the drug. …”

Image 4_Impact of DRG policy on the performance of tertiary hospital inpatient services in Chongqing, China: an interrupted time series study, 2020–2023.png by Yunyu Liu (11739052)

Image 1_Impact of DRG policy on the performance of tertiary hospital inpatient services in Chongqing, China: an interrupted time series study, 2020–2023.png by Yunyu Liu (11739052)

Image 2_Impact of DRG policy on the performance of tertiary hospital inpatient services in Chongqing, China: an interrupted time series study, 2020–2023.png by Yunyu Liu (11739052)

Image 3_Impact of DRG policy on the performance of tertiary hospital inpatient services in Chongqing, China: an interrupted time series study, 2020–2023.png by Yunyu Liu (11739052)

The impact of anesthesia and positioning on cerebral blood flow and pressure in patients undergoing laparoscopic surgery: an randomised observational study by alon lord (20342469)

Differences between patients and controls. by Jolanda Malamud (19727472)

The effects of emotional expressivity and self-efficacy levels of individuals with substance addiction on treatment compliance by Murat Toprak (19853862)

“…It was concluded that as the level of emotional expressivity decreased, the treatment motivation levels of the individuals increased and the increase in the self-efficacy levels was a factor that boosted individuals’ treatment compliance.…”

Modulation of cardiovascular function by rooibos in adults at risk for cardiovascular disease by Maria Diana Hartnick (7007012)

“…The placebo (p=0.300) and green rooibos (p=0.292) groups demonstrated no significant changes for the left ventricle mass (LVM), while the fermented rooibos group showed a significant (p=0.015) decreased mass (from 204.1 g ± 7.1 g to 191.4 g ± 6.7 g). …”

Table 1_GRHL2-HER3 and E-cadherin mediate EGFR-bypass drug resistance in lung cancer cells.xlsx by Fumiya Ito (14833366)

Data Sheet 1_GRHL2-HER3 and E-cadherin mediate EGFR-bypass drug resistance in lung cancer cells.pdf by Fumiya Ito (14833366)

Table 1_Burden of heart failure attributable to chronic kidney disease in older adults (1990–2021): an analysis from the global burden of disease study.docx by Wenli Liu (400084)

“…Background<p>Heart failure (HF) is a critical global health issue, with chronic kidney disease (CKD) as a significant contributing factor. …”

Table 2_Burden of heart failure attributable to chronic kidney disease in older adults (1990–2021): an analysis from the global burden of disease study.docx by Wenli Liu (400084)

“…Background<p>Heart failure (HF) is a critical global health issue, with chronic kidney disease (CKD) as a significant contributing factor. …”

Table 3_Burden of heart failure attributable to chronic kidney disease in older adults (1990–2021): an analysis from the global burden of disease study.docx by Wenli Liu (400084)

“…Background<p>Heart failure (HF) is a critical global health issue, with chronic kidney disease (CKD) as a significant contributing factor. …”

Table 4_Burden of heart failure attributable to chronic kidney disease in older adults (1990–2021): an analysis from the global burden of disease study.docx by Wenli Liu (400084)

“…Background<p>Heart failure (HF) is a critical global health issue, with chronic kidney disease (CKD) as a significant contributing factor. …”

Data Sheet 1_Global burden and trends of childhood non-Hodgkin lymphoma from 1990 to 2021.pdf by Jing Xie (180526)

“…Background<p>Childhood non-Hodgkin lymphoma (NHL) is a significant contributor to pediatric cancer morbidity and mortality worldwide. …”

Table 2_Global burden and trends of childhood non-Hodgkin lymphoma from 1990 to 2021.docx by Jing Xie (180526)

“…Background<p>Childhood non-Hodgkin lymphoma (NHL) is a significant contributor to pediatric cancer morbidity and mortality worldwide. …”